Repurposing Lithium for Parkinson's Disease: a RCT

Running, not enrolling · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Parkinson Disease

In brief

This study will examine the effects of lithium 20mg/day compared to placebo on MRI and blood-based biomarkers among 20 early-stage Parkinson's disease patients.

Key facts

Study ID
NCT06339034
Run by
State University of New York at Buffalo
People needed
20
Starts
2024-07-03
Expected to finish
2026-09-01
Last updated by the study team
2026-06-16

Who can join

Age: 40 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.